ODDITY Tech (NASDAQ:ODD) vs. Medifast (NYSE:MED) Head to Head Analysis

Medifast (NYSE:MED) and ODDITY Tech (NASDAQ:ODD) are both small-cap consumer staples companies, but which is the superior stock? We will compare the two companies based on the strength of their valuation, dividends, profitability, earnings, risk, analyst recommendations and institutional ownership.

Volatility & Risk

Medifast has a beta of 0.65, meaning that its stock price is 35% less volatile than the S&P 500. Comparatively, ODDITY Tech has a beta of 2.38, meaning that its stock price is 138% more volatile than the S&P 500.

Profitability

This table compares Medifast and ODDITY Tech’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Medifast	-8.08%	-6.69%	-5.25%
ODDITY Tech	6.97%	15.38%	4.99%

Institutional and Insider Ownership

95.5% of Medifast shares are owned by institutional investors. Comparatively, 35.9% of ODDITY Tech shares are owned by institutional investors. 3.7% of Medifast shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Earnings and Valuation

This table compares Medifast and ODDITY Tech”s revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Medifast	$385.79 million	0.36	-$18.67 million	($2.33)	-5.26
ODDITY Tech	$809.84 million	1.03	$110.75 million	$0.79	18.39

ODDITY Tech has higher revenue and earnings than Medifast. Medifast is trading at a lower price-to-earnings ratio than ODDITY Tech, indicating that it is currently the more affordable of the two stocks.

Analyst Ratings

This is a breakdown of recent ratings and recommmendations for Medifast and ODDITY Tech, as provided by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Medifast	1	2	0	0	1.67
ODDITY Tech	4	9	0	0	1.69

Medifast currently has a consensus price target of $12.00, suggesting a potential downside of 2.12%. ODDITY Tech has a consensus price target of $25.39, suggesting a potential upside of 74.72%. Given ODDITY Tech’s stronger consensus rating and higher probable upside, analysts plainly believe ODDITY Tech is more favorable than Medifast.

Summary

ODDITY Tech beats Medifast on 11 of the 13 factors compared between the two stocks.

About Medifast

Medifast, Inc., through its subsidiaries, engages in the manufacture and sale of weight loss, weight management, and healthy living products in the United States and the Asia-Pacific. It offers bars, puffs, cereal, crunchers, drinks, hearty choices, oatmeal, pancakes, pudding, soft serve, shakes, smoothies, soft bakes, and soups under the OPTAVIA, OPTAVIA ACTIVE, and Optimal Health brand names. The company markets its products through point-of-sale transactions, as well as through ecommerce platform. Medifast, Inc. was founded in 1980 and is headquartered in Baltimore, Maryland.

About ODDITY Tech

Oddity Tech Ltd. operates as a consumer tech company that builds digital-first brands for the beauty and wellness industries in the United States and internationally. It serves consumers worldwide through its AI-driven online platform, which uses data science, machine learning, and computer vision capabilities to identify consumer needs, and develop solutions in the form of beauty and wellness products. The company sells beauty, hair, and skin products under the IL MAKIAGE and SpoiledChild brands. In addition, it operates ODDITY LABS, a biotechnology center, which develops various ingredients, including novel molecules, probiotics, and peptides for beauty and wellness products. Oddity Tech Ltd. was incorporated in 2013 and is headquartered in Tel Aviv, Israel.